Does DABRAFENIB Cause Electrocardiogram qt prolonged? 112 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 112 reports of Electrocardiogram qt prolonged have been filed in association with DABRAFENIB (Tafinlar). This represents 0.6% of all adverse event reports for DABRAFENIB.
112
Reports of Electrocardiogram qt prolonged with DABRAFENIB
0.6%
of all DABRAFENIB reports
11
Deaths
23
Hospitalizations
How Dangerous Is Electrocardiogram qt prolonged From DABRAFENIB?
Of the 112 reports, 11 (9.8%) resulted in death, 23 (20.5%) required hospitalization, and 6 (5.4%) were considered life-threatening.
Is Electrocardiogram qt prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABRAFENIB. However, 112 reports have been filed with the FAERS database.
What Other Side Effects Does DABRAFENIB Cause?
Pyrexia (3,788)
Death (2,740)
Malignant neoplasm progression (1,667)
Fatigue (1,328)
Nausea (1,300)
Chills (1,235)
Rash (1,078)
Vomiting (907)
Diarrhoea (901)
Headache (697)
What Other Drugs Cause Electrocardiogram qt prolonged?
QUETIAPINE (1,869)
OLANZAPINE (1,325)
RIBOCICLIB (1,020)
AMIODARONE (1,000)
HYDROXYCHLOROQUINE (992)
CLOZAPINE (958)
CITALOPRAM HYDROBROMIDE (917)
ESCITALOPRAM OXALATE (899)
ONDANSETRON (881)
BUPROPION (853)
Which DABRAFENIB Alternatives Have Lower Electrocardiogram qt prolonged Risk?
DABRAFENIB vs DABRAFENIB\TRAMETINIB
DABRAFENIB vs DACARBAZINE
DABRAFENIB vs DACLATASVIR
DABRAFENIB vs DACLIZUMAB
DABRAFENIB vs DACOMITINIB